Tokio Marine Asset Management Co. Ltd. raised its stake in shares of CME Group Inc. (NASDAQ:CME) by 17.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,578 shares of the company’s stock after buying an additional 4,042 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in CME Group were worth $2,686,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in CME. Parametrica Management Ltd purchased a new position in shares of CME Group during the second quarter worth $212,000. Franklin Resources Inc. bought a new stake in CME Group during the first quarter valued at $222,000. Financial Architects Inc bought a new stake in CME Group during the second quarter valued at $234,000. EFG Asset Management Americas Corp. bought a new stake in CME Group during the first quarter valued at $244,000. Finally, Windward Capital Management Co. CA increased its stake in CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock valued at $256,000 after buying an additional 25 shares during the period. 80.29% of the stock is owned by hedge funds and other institutional investors.
CME Group Inc. (NASDAQ:CME) traded down 1.50% on Thursday, reaching $104.72. 2,987,809 shares of the company traded hands. The stock’s 50 day moving average price is $106.77 and its 200 day moving average price is $99.04. The company has a market capitalization of $35.48 billion, a PE ratio of 26.44 and a beta of 0.85. CME Group Inc. has a one year low of $81.87 and a one year high of $110.35.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The business earned $906 million during the quarter, compared to analyst estimates of $897.84 million. During the same period in the prior year, the business earned $0.95 EPS. The company’s revenue for the quarter was up 10.5% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post $4.44 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were issued a $0.60 dividend. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.40 annualized dividend and a yield of 2.29%. CME Group’s dividend payout ratio (DPR) is presently 60.61%.
Several equities research analysts have weighed in on CME shares. Credit Suisse Group AG decreased their price target on shares of CME Group from $100.00 to $94.00 and set a “neutral” rating for the company in a research note on Wednesday, June 1st. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Monday, June 20th. Credit Agricole SA decreased their price target on shares of CME Group from $100.00 to $95.00 and set an “underperform” rating for the company in a research note on Thursday, July 14th. Barclays PLC decreased their price target on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a research note on Friday, July 29th. Finally, Deutsche Bank AG lifted their price target on shares of CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a research note on Friday, July 29th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $102.89.
In related news, CEO Phupinder Gill sold 20,080 shares of the stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $104.54, for a total value of $2,099,163.20. Following the completion of the transaction, the chief executive officer now directly owns 154,141 shares in the company, valued at approximately $16,113,900.14. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director James E. Oliff sold 1,000 shares of the stock in a transaction dated Friday, July 15th. The stock was sold at an average price of $102.30, for a total transaction of $102,300.00. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.